Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Revenue

Arovella Therapeutics had revenue of 3.44M AUD in the half year ending December 31, 2024, with 140.79% growth. This brings the company's revenue in the last twelve months to 3.45M, up 75.02% year-over-year. In the fiscal year ending June 30, 2024, Arovella Therapeutics had annual revenue of 1.95M with 34.20% growth.

• Revenue (ttm): 3.45M
• Revenue Growth: +75.02%
• P/S Ratio: 36.20
• Revenue / Employee: 127.69K
• Employees: 27
• Market Cap: 124.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.95M	497.46K	34.20%
Jun 30, 2023	1.45M	1.16M	391.76%
Jun 30, 2022	295.81K	-693.91K	-70.11%
Jun 30, 2021	989.72K	-261.71K	-20.91%
Jun 30, 2020	1.25M	644.00	0.05%